Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 7Sarcoma, Ewing 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Lymphoma, Large B-Cell, Diffuse 3Sarcoma, Clear Cell 2Rhabdomyosarcoma 2Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neurofibrosarcoma 2Nerve Sheath Neoplasms 2Lymphoma 2Liposarcoma 2Hodgkin Disease 2Histiocytoma, Angiomatoid Fibrous 2Granuloma, Plasma Cell 2Fibrosarcoma 2Dermatofibrosarcoma 2Chondrosarcoma, Extraskeletal Myxoid 2Wilms Tumor 1Vascular Neoplasms 1Teratoma 1Solitary Fibrous Tumors 1Smooth Muscle Tumor 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Pleuropulmonary blastoma 1Perivascular Epithelioid Cell Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasms, Adipose Tissue 1

Interventions

Radiotherapy 1Mesna 1Ifosfamide 1ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ichthyosis, X-Linked × Ifosfamide × 90 days × Clear all
NCT05813327 2026-04-20

Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma

Washington University School of Medicine

Phase 1 Active not recruiting
6 enrolled
Sarcoma

Sarcoma, Ichthyosis, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡